Effect of GLP1 receptor agonist on gastric emptying rate in type 2 DM
Not Applicable
- Conditions
- type2 DM
- Registration Number
- JPRN-UMIN000042797
- Lead Sponsor
- Kansai Electric Power medical Intitute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects with type 1 diabetes, severe diabetic autonomic neuropathy, gastrointestinal tract disease including gastroparesis, history of gastrointestinal operation, cardiac disease, pulmonary disease, pancreatic disease, thyroid disease, liver disease, renal disease, alcohol or drug abuse, anti-diabetes drugs other than biguanides or sulfonylureas, diabetogenic medication, malignancy, or pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in glucose, insulin, and gastric emptying rate after administration of GLP-1RA for 12 weeks
- Secondary Outcome Measures
Name Time Method Changes in glucose, insulin, and gastric emptying rate after administration of GLP-1RA for 12 weeks